# Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation

> **NCT03211897** · — · COMPLETED · sponsor: **Hennepin Healthcare Research Institute** · enrollment: 737 (actual)

## Conditions studied

- Agitation,Psychomotor

## Interventions

- **DRUG:** Haloperidol Injection
- **DRUG:** Ziprasidone Injection
- **DRUG:** OLANZapine Injection
- **DRUG:** Midazolam injection

## Key facts

- **NCT ID:** NCT03211897
- **Lead sponsor:** Hennepin Healthcare Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2017-10-01
- **Final completion:** 2017-10-01
- **Target enrollment:** 737 (ACTUAL)
- **Last updated:** 2018-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03211897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03211897, "Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03211897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*